Paul Mathew, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC) (NCT02500901) | Paul Mathew, MD | 2016-03-01 |
Track Paul Mathew, MD automatically
Every clearance here is in the API, with alerts when new ones post.